Rapport Therapeutics, Inc. · NASDAQ:RAPP

Ceesay Abraham sold 4,522 Rapport Therapeutics, Inc. shares (Form 4)

Traded Oct 6 to Oct 7, 2026 · Filed Oct 8, 2026

From Oct 6 to Oct 7, 2026, Ceesay Abraham (Director, Chief Executive Officer) sold 4,522 Rapport Therapeutics, Inc. shares at an average US$31.68 for US$143K under a trading plan, leaving 452,245 shares. Filed Oct 8, 2026 (Form 4).

Sold
4,522 shares
Price
US$31.68 average (US$30.66 to US$32.03)
Value
US$143K
Holding after
452,245 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 6, 2026Common StockSale3,375US$32.03453,392Direct
Oct 7, 2026Common StockSale1,147US$30.66452,245Direct

Source

View original at SEC

Related